Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Riskified
RSKD
$863M
| $2.86M | ﹤0.01% |
588,454
+457,177
| +348% | +$2.29M |
|
1777
Visteon
VC
$2.86B
| $2.86M | ﹤0.01% |
+19,900
| New | +$2.84M |
|
1778
Stepan Co
SCL
$1.48B
| $2.86M | ﹤0.01% |
29,900
-1,100
| -4% | -$105K |
|
1779
Quad
QUAD
$506M
| $2.85M | ﹤0.01% |
758,300
-10,000
| -1% | -$36.1K |
|
1780
Arrow Electronics
ARW
$10.6B
| $2.84M | ﹤0.01% |
+19,800
| New | +$2.46M |
|
1781
Glaukos
GKOS
$11.2B
| $2.83M | ﹤0.01% |
39,792
+12,600
| +46% | +$723K |
|
|
FARO
1782
DELISTED
Faro Technologies
FARO
| $2.83M | ﹤0.01% |
174,742
+131,100
| +300% | +$2.32M |
|
1783
Kodiak Sciences
KOD
$2.5B
| $2.83M | ﹤0.01% |
409,500
+78,500
| +24% | +$480K |
|
1784
Maximus
MMS
$2.94B
| $2.82M | ﹤0.01% |
33,400
-55,600
| -62% | -$4.57M |
|
1785
Sasol
SSL
$7.17B
| $2.82M | ﹤0.01% |
228,000
+47,400
| +26% | +$610K |
|
1786
Monarch Casino & Resort
MCRI
$2.2B
| $2.82M | ﹤0.01% |
40,000
+4,417
| +12% | +$308K |
|
|
AMNB
1787
DELISTED
American National Bankshares Inc
AMNB
| $2.81M | ﹤0.01% |
96,991
+3,400
| +4% | +$97.8K |
|
|
ESGR
1788
DELISTED
Enstar Group
ESGR
| $2.81M | ﹤0.01% |
11,500
-800
| -7% | -$198K |
|
1789
Shore Bancshares
SHBI
$799M
| $2.8M | ﹤0.01% |
242,495
+12,400
| +5% | +$152K |
|
1790
First Trust Global Tactical Commodity Strategy Fund
FTGC
$3.07B
| $2.8M | ﹤0.01% |
123,000
+3,712
| +3% | +$85.3K |
|
|
SWI
1791
DELISTED
SolarWinds Corporation Common Stock
SWI
| $2.8M | ﹤0.01% |
272,700
-43,898
| -14% | -$400K |
|
1792
Amplify Energy
AMPY
$200M
| $2.8M | ﹤0.01% |
413,100
-267,600
| -39% | -$1.86M |
|
|
TSE
1793
DELISTED
Trinseo
TSE
| $2.8M | ﹤0.01% |
220,700
-46,700
| -17% | -$754K |
|
1794
iShares MSCI Mexico ETF
EWW
$1.87B
| $2.79M | ﹤0.01% |
44,793
+10,600
| +31% | +$648K |
|
1795
Global X MLP ETF
MLPA
$2.28B
| $2.77M | ﹤0.01% |
64,476
+14,419
| +29% | +$606K |
|
1796
American Vanguard Corp
AVD
$62.8M
| $2.77M | ﹤0.01% |
154,752
+107,600
| +228% | +$1.99M |
|
1797
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.85B
| $2.76M | ﹤0.01% |
41,600
+16,200
| +64% | +$1.08M |
|
1798
MannKind Corp
MNKD
$1.2B
| $2.75M | ﹤0.01% |
676,345
-495,000
| -42% | -$2.06M |
|
1799
Keros Therapeutics
KROS
$211M
| $2.75M | ﹤0.01% |
68,400
-52,700
| -44% | -$2.31M |
|
1800
Vita Coco
COCO
$3.77B
| $2.75M | ﹤0.01% |
+102,200
| New | +$2.49M |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.